Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing MolPort-001-792-519 listed in the FDA Orange Book. Original Data : FDA Website

Client Email

Product

MolPort-001-792-519
FDA Orange Book

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

MolPort-001-792-519

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 7 USDMF, 1 CEP/COS, 4 EU WC, 6 NDC API, 11 Listed Suppliers, $ API Reference Price

19 API Suppliers
7 USDMF
1 CEP/COS
4 EU WC
6 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 19 FDA Orange Book, 16 Europe, 1 South Africa, 4 Listed Dossiers

40 FDF Dossiers
19 FDA Orange Book
16 Europe
1 South Africa
4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG, TABLET;ORAL - 500MG

TABLET;ORAL - 250MG
TABLET;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 5 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 7 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 24 Kerry, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem

1 SPI Pharma
1 DKSH
1 Jai Radhe Sales
5 Boai NKY Pharmaceuticals Ltd
11 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
1 Alcedo Pharmachem
8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
17 BASF
7 DFE Pharma
6 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
2 Ingredion Pharma Solutions
24 Kerry
14 Microlex e.U
1 Nanjing Bold Chemical
2 Novo Excipients
4 Pharmatrans-Sanaq
4 Pluviaendo
4 Prachin Chemical
14 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
11 Sigachi Industries
2 Ulanqab Kema New Material
4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 36 Disintegrants & Superdisintegrants, 35 Direct Compression, 23 Granulation, 17 Thickeners and Stabilizers, 15 Lubricants & Glidants, 14 Co-Processed Excipients, 10 Solubilizers, 7 Controlled & Modified Release, 7 Coating Systems & Additives, 7 Film Formers & Plasticizers, 5 Chewable & Orodispersible Aids, 4 Emulsifying Agents, 4 Parenteral, 2 Topical, 2 Rheology Modifiers, 2 Taste Masking, 1 API Stability Enhancers

58 Fillers, Diluents & Binders
36 Disintegrants & Superdisintegrants
35 Direct Compression
23 Granulation
17 Thickeners and Stabilizers
15 Lubricants & Glidants
14 Co-Processed Excipients
10 Solubilizers
7 Controlled & Modified Release
7 Coating Systems & Additives
7 Film Formers & Plasticizers
5 Chewable & Orodispersible Aids
4 Emulsifying Agents
4 Parenteral
2 Topical
2 Rheology Modifiers
2 Taste Masking
1 API Stability Enhancers

DIGITAL CONTENT

4 NEWS #PharmaBuzz

4 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 7 Finished Drug Prices

1 US Medicaid Prescriptions
7 Finished Drug Prices

MARKET PLACE

9 APIs, 1 FDF Dossiers

9 APIs
1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 5 Others

1 EDQM
1 USP
5 Others

$ API Ref.Price (USD/KG) : 84 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

19 All

01 2STRIDES PHARMA

02 1ALVOGEN

03 2CHARTWELL MOLECULES

04 2DASH PHARMS

05 2HIKMA

06 2ODYSSEY PHARMS

07 2SIGMAPHARM LABS LLC

08 2TEVA WOMENS

09 3WATSON LABS

10 1WATSON LABS TEVA

filter Dosage Reset all filters

19 All

01 19TABLET;ORAL

filter Regulatory Info Reset all filters

19 All

01 14DISCN

02 5RX

filter Brand Name Reset all filters

19 All

01 4ANTABUSE

02 15DISULFIRAM

filter RLD Reset all filters

19 All

01 15No

02 4Yes

FDF Dossiers
FDA Orange Book
Europe
South Africa
Listed Dossiers

List of Suppliers

Product Main Page

01

STRIDES PHARMA

CPhI Worldwide, Milan

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

Contact Supplier

Digital Content

RLD : No

TE Code :

Brand Name : DISULFIRAM

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Approval Date : 1984-08-14

Application Number : 88792

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

Product Web Link

Digital Content

02

STRIDES PHARMA

CPhI Worldwide, Milan

Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Contact Supplier

Contact Supplier

Digital Content

RLD : No

TE Code :

Brand Name : DISULFIRAM

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Approval Date : 1984-08-14

Application Number : 88793

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

Product Web Link

Digital Content

03

WATSON LABS

Boulder Peptide 2024

Not Confirmed

WATSON LABS

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

Brand Name : DISULFIRAM

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Approval Date : 1982-01-01

Application Number : 86889

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

WATSON LABS TEVA

Boulder Peptide 2024

Not Confirmed

WATSON LABS TEVA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

Brand Name : DISULFIRAM

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Approval Date : 1982-01-01

Application Number : 86890

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

WATSON LABS

Boulder Peptide 2024

Not Confirmed

WATSON LABS

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

Brand Name : DISULFIRAM

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Approval Date : 1983-08-05

Application Number : 87973

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

WATSON LABS

Boulder Peptide 2024

Not Confirmed

WATSON LABS

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code :

Brand Name : DISULFIRAM

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Approval Date : 1983-08-05

Application Number : 87974

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

ODYSSEY PHARMS

Boulder Peptide 2024

Not Confirmed

ODYSSEY PHARMS

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

Brand Name : ANTABUSE

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG

Approval Date : 1983-12-08

Application Number : 88482

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

08

ODYSSEY PHARMS

Boulder Peptide 2024

Not Confirmed

ODYSSEY PHARMS

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

Brand Name : ANTABUSE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Approval Date : 1983-12-08

Application Number : 88483

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

09

TEVA WOMENS

Boulder Peptide 2024

Not Confirmed

TEVA WOMENS

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

Brand Name : ANTABUSE

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1982-01-01

Application Number : 7883

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

TEVA WOMENS

Boulder Peptide 2024

Not Confirmed

TEVA WOMENS

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

Brand Name : ANTABUSE

Dosage Form : TABLET;ORAL

Dosage Strength : 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1982-01-01

Application Number : 7883

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?